Literature DB >> 22921077

Interpreting human follicular recruitment and antimüllerian hormone concentrations throughout life.

Richard Fleming1, Tom W Kelsey, Richard A Anderson, W Hamish Wallace, Scott M Nelson.   

Abstract

The changes in the relationships between circulating antimüllerian hormone, the size of the primordial follicle pool, and follicular recruitment before and through the reproductive years have now been clarified, and show dynamic changes through sexual development. The constant relationship between the number of follicles and circulating antimüllerian hormone exists only after the age of 25 years, implying that the association between follicular recruitment and follicular survival to the later stages of development is not constant across the reproductive life course. This commentary assesses the factors that may underlie these relationships and their clinical implications for reproductive health.
Copyright © 2012 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22921077     DOI： 10.1016/j.fertnstert.2012.07.1114

Source DB:  PubMed          Journal:  Fertil Steril        ISSN： 0015-0282            Impact factor:   7.329


  15 in total

1.  Reduced serum levels of anti-Müllerian hormone in females with inherited bone marrow failure syndromes.

Authors:  Martha M Sklavos; Pamela Stratton; Neelam Giri; Blanche P Alter; Sharon A Savage; Ligia A Pinto
Journal:  J Clin Endocrinol Metab       Date:  2014-11-18       Impact factor: 5.958

2.  Cognitive changes across the menopause transition: A longitudinal evaluation of the impact of age and ovarian status on spatial memory.

Authors:  Stephanie V Koebele; Sarah E Mennenga; Ryoko Hiroi; Alicia M Quihuis; Lauren T Hewitt; Mallori L Poisson; Christina George; Loretta P Mayer; Cheryl A Dyer; Leona S Aiken; Laurence M Demers; Catherine Carson; Heather A Bimonte-Nelson
Journal:  Horm Behav       Date:  2016-10-26       Impact factor: 3.587

3.  Demographic, lifestyle, and other factors in relation to antimüllerian hormone levels in mostly late premenopausal women.

Authors:  Seungyoun Jung; Naomi Allen; Alan A Arslan; Laura Baglietto; Louise A Brinton; Brian L Egleston; Roni Falk; Renée T Fortner; Kathy J Helzlsouer; Annika Idahl; Rudolph Kaaks; Eva Lundin; Melissa Merritt; Charlotte Onland-Moret; Sabina Rinaldi; María-José Sánchez; Sabina Sieri; Helena Schock; Xiao-Ou Shu; Patrick M Sluss; Paul N Staats; Ruth C Travis; Anne Tjønneland; Antonia Trichopoulou; Shelley Tworoger; Kala Visvanathan; Vittorio Krogh; Elisabete Weiderpass; Anne Zeleniuch-Jacquotte; Wei Zheng; Joanne F Dorgan
Journal:  Fertil Steril       Date:  2017-04       Impact factor: 7.329

4.  Pubertal development and primary ovarian insufficiency in female survivors of embryonal brain tumors following risk-adapted craniospinal irradiation and adjuvant chemotherapy.

Authors:  Mariko DeWire; Daniel M Green; Charles A Sklar; Thomas E Merchant; Dana Wallace; Tong Lin; Tamara Vern-Gross; Larry E Kun; Matthew J Krasin; James M Boyett; Karen D Wright; Cynthia Wetmore; Alberto Broniscer; Amar Gajjar
Journal:  Pediatr Blood Cancer       Date:  2014-10-18       Impact factor: 3.167

5.  Ovarian Reserve Assessed by the Anti-Mullerian Hormone and Reproductive Health Parameters in Women With Crohn´s Disease, a Case-Control Study.

Authors:  T Koller; J Kollerová; T Hlavatý; B Kadlečková; J Payer
Journal:  Physiol Res       Date:  2021-11-30       Impact factor: 1.881

6.  Anti-Müllerian hormone deficiency in females with Fanconi anemia.

Authors:  Martha M Sklavos; Neelam Giri; Pamela Stratton; Blanche P Alter; Ligia A Pinto
Journal:  J Clin Endocrinol Metab       Date:  2014-01-17       Impact factor: 5.958

Review 7.  Recommendations for Premature Ovarian Insufficiency Surveillance for Female Survivors of Childhood, Adolescent, and Young Adult Cancer: A Report From the International Late Effects of Childhood Cancer Guideline Harmonization Group in Collaboration With the PanCareSurFup Consortium.

Authors:  Wendy van Dorp; Renée L Mulder; Leontien C M Kremer; Melissa M Hudson; Marry M van den Heuvel-Eibrink; Marleen H van den Berg; Jennifer M Levine; Eline van Dulmen-den Broeder; Natascia di Iorgi; Assunta Albanese; Saro H Armenian; Smita Bhatia; Louis S Constine; Andreas Corrias; Rebecca Deans; Uta Dirksen; Clarisa R Gracia; Lars Hjorth; Leah Kroon; Cornelis B Lambalk; Wendy Landier; Gill Levitt; Alison Leiper; Lillian Meacham; Alesandro Mussa; Sebastian J Neggers; Kevin C Oeffinger; Alberto Revelli; Hanneke M van Santen; Roderick Skinner; Andrew Toogood; William H Wallace; Riccardo Haupt
Journal:  J Clin Oncol       Date:  2016-07-25       Impact factor: 44.544

Review 8.  Fertility preservation in women with cancer.

Authors:  Michel De Vos; Johan Smitz; Teresa K Woodruff
Journal:  Lancet       Date:  2014-10-04       Impact factor: 79.321

9.  Breast Cancer Risk Factors and Circulating Anti-Müllerian Hormone Concentration in Healthy Premenopausal Women.

Authors:  Tess V Clendenen; Wenzhen Ge; Karen L Koenig; Yelena Afanasyeva; Claudia Agnoli; Elizabeth Bertone-Johnson; Louise A Brinton; Farbod Darvishian; Joanne F Dorgan; A Heather Eliassen; Roni T Falk; Göran Hallmans; Susan E Hankinson; Judith Hoffman-Bolton; Timothy J Key; Vittorio Krogh; Hazel B Nichols; Dale P Sandler; Minouk J Schoemaker; Patrick M Sluss; Malin Sund; Anthony J Swerdlow; Kala Visvanathan; Mengling Liu; Anne Zeleniuch-Jacquotte
Journal:  J Clin Endocrinol Metab       Date:  2021-10-21       Impact factor: 6.134

10.  Anti-müllerian hormone is not associated with cardiometabolic risk factors in adolescent females.

Authors:  Emma L Anderson; Abigail Fraser; William McNally; Naveed Sattar; Hany Lashen; Richard Fleming; Scott M Nelson; Debbie A Lawlor
Journal:  PLoS One       Date:  2013-05-31       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.